Navana Pharmaceuticals Statistics

Total Valuation

DSE:NAVANAPHAR has a market cap or net worth of BDT 5.56 billion. The enterprise value is 10.37 billion.

Market Cap	5.56B
Enterprise Value	10.37B

Important Dates

The next estimated earnings date is Sunday, April 13, 2025.

Earnings Date	Apr 13, 2025
Ex-Dividend Date	Nov 20, 2024

Share Statistics

DSE:NAVANAPHAR has 107.42 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	n/a
Shares Outstanding	107.42M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	35.49%
Owned by Institutions (%)	n/a
Float	69.30M

Valuation Ratios

The trailing PE ratio is 13.19.

PE Ratio	13.19
Forward PE	n/a
PS Ratio	0.70
PB Ratio	1.17
P/TBV Ratio	1.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.16, with an EV/FCF ratio of -219.45.

EV / Earnings	24.59
EV / Sales	1.30
EV / EBITDA	7.16
EV / EBIT	8.32
EV / FCF	-219.45

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 1.08.

Current Ratio	0.91
Quick Ratio	0.22
Debt / Equity	1.08
Debt / EBITDA	3.54
Debt / FCF	-108.58
Interest Coverage	1.88

Financial Efficiency

Return on equity (ROE) is 9.19% and return on invested capital (ROIC) is 8.20%.

Return on Equity (ROE)	9.19%
Return on Assets (ROA)	7.20%
Return on Invested Capital (ROIC)	8.20%
Return on Capital Employed (ROCE)	23.98%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	4,408
Asset Turnover	0.74
Inventory Turnover	2.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.06% in the last 52 weeks. The beta is -0.15, so DSE:NAVANAPHAR's price volatility has been lower than the market average.

Beta (5Y)	-0.15
52-Week Price Change	-44.06%
50-Day Moving Average	47.71
200-Day Moving Average	65.23
Relative Strength Index (RSI)	60.52
Average Volume (20 Days)	546,981

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:NAVANAPHAR had revenue of BDT 7.98 billion and earned 421.76 million in profits. Earnings per share was 3.93.

Revenue	7.98B
Gross Profit	3.62B
Operating Income	1.25B
Pretax Income	564.86M
Net Income	421.76M
EBITDA	1.41B
EBIT	1.25B
Earnings Per Share (EPS)	3.93

Full Income Statement

Balance Sheet

The company has 282.57 million in cash and 5.13 billion in debt, giving a net cash position of -4.81 billion or -44.77 per share.

Cash & Cash Equivalents	282.57M
Total Debt	5.13B
Net Cash	-4.81B
Net Cash Per Share	-44.77
Equity (Book Value)	4.74B
Book Value Per Share	44.10
Working Capital	-531.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 953.44 million and capital expenditures -1.00 billion, giving a free cash flow of -47.27 million.

Operating Cash Flow	953.44M
Capital Expenditures	-1.00B
Free Cash Flow	-47.27M
FCF Per Share	-0.44

Full Cash Flow Statement

Margins

Gross margin is 45.42%, with operating and profit margins of 15.63% and 5.29%.

Gross Margin	45.42%
Operating Margin	15.63%
Pretax Margin	7.08%
Profit Margin	5.29%
EBITDA Margin	17.67%
EBIT Margin	15.63%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 2.67%.

Dividend Per Share	1.40
Dividend Yield	2.67%
Dividend Growth (YoY)	7.69%
Years of Dividend Growth	3
Payout Ratio	32.56%
Buyback Yield	-0.11%
Shareholder Yield	2.56%
Earnings Yield	7.58%
FCF Yield	-0.85%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DSE:NAVANAPHAR has an Altman Z-Score of 1.87. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.87
Piotroski F-Score	n/a